APM Steam Offers Unparalleled Heat Exchanger Assessment and Testing Services for Biopharmaceutical and Pharmaceutical Facilities

Ardena's Nanomedicines Facility Marks €20 Million Expansion with first GMP approval

Oss, The Netherlands: Ardena, a leading Contract Development and Manufacturing Organization (CDMO) specializing in bringing molecules to clinic, has received Good Manufacturing Practice (GMP) approval from the Dutch Healthcare Authority for its new analytical laboratories in its expanded nanomedicines facility.

CPHI North America experts ‘mid-sized domestic CDMOs need to invest in operational efficiencies to drive “real” reshoring’

Supply chain resilience and new partner sourcing to benefit from a boom in outsourcing in 2025

SYGNATURE DISCOVERY RECEIVES ECOVADIS AWARD FOR SUSTAINABLE EXCELLENCE

TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology

Lonza customers can now access TriLink’s CleanCap® mRNA capping technology for non-commercial use, enabling further development of critical mRNA therapeutics.

Watson-Marlow advances its OEM panel mount solution DriveSure with latest technology

Watson-Marlow Fluid Technology Solutions (WMFTS) has advanced DriveSure® with the latest technology to offer a complete peristaltic panel mount pump solution for original equipment manufacturers (OEMs).

Creative Biogene Develops New Platforms for circRNA Stable Cell Lines

Creative Biogene Unveils Advanced mRNA In Vivo Delivery Kit Engineered for Superior Performance in Targeting Multiple Organs

Helping to Diagnose and Treat Heart Disease, Tumors, and Other Conditions at the Intersection of Physics, Molecular Biology, and High-Performance Computing

ChargePoint to expand product range by investing in a dedicated multi-million-pound single-use manufacturing facility

Model Medicines Appoints Dr. Launa Aspeslet as Senior Scientific & Clinical Advisor

Model Medicines has appointed Dr. Launa Aspeslet as Senior Scientific & Clinical Advisor. With over 25 years of leadership experience in the life sciences industry, Dr. Aspeslet will provide strategic guidance to support the company's growth and advance its pipeline of novel therapeutics. Her appointment comes as Model Medicines announces the "AI Pharma Code," a set of criteria that includes identifying novel biology, new chemical entities, high zero-shot hit rates, low Tanimoto scores, a diverse pipeline across biology and disease, and preclinical proof of concept. Dr. Aspeslet's expertise will be invaluable to Model Medicines' mission to revolutionize drug discovery and development.

Watson-Marlow to showcase latest chemical metering and dosing pump for higher flows at Water Equipment Show

atson-Marlow Fluid Technology Solutions (WMFTS), a leader in peristaltic pumps and associated fluid path technologies, will showcase its diverse product range at the Water Equipment Show hosted in Telford, UK, on 16th May.

SpecialtyVETPATH Taps Proscia For A Full Transformation Of Its Pathology Operations

Advancing diagnosis and research with an enterprise software platform

Novel Concepts Medical Announces a Breakthrough Colon Cancer Study

Novel Concepts Medical’s case study shows improvement in a colon cancer patient with metastases in his liver and shrinkage of his tumor size after using our plant-based treatment.

Clarapath Forms Strategic Collaboration with Mayo Clinic to Advance Pathology Tissue Processing

Clarapath forms strategic collaboration with Mayo Clinic to advance pathology tissue processing. Robotics, AI and automation help improve patient outcomes and solve laboratory labor shortages.

Community Health Network Selects Biofourmis to Help Drive Care-at-Home Outcomes Across the Continuum

https://www.prnewswire.com/news-releases/community-health-network-selects-biofourmis-to-help-drive-care-at-home-outcomes-across-the-continuum-302124335.html?tc=eml_cleartime

DrFirst and PatchRx Partnership Combines Medication History with Daily Patient Adherence Data

https://www.prnewswire.com/news-releases/drfirst-and-patchrx-partnership-combines-medication-history-with-daily-patient-adherence-data-302124060.html?tc=eml_cleartime

CG LIFE SPECIALTY AGENCY THE MARKET ELEMENT RELAUNCHES AS ELEMENT CG

This brand relaunch emphasizes a focus on building emerging life science and biopharma brands with complementary client offerings as part of the larger CG Life platform.

Cyclo Therapeutics, Inc. Announced the Start of its Phase 2b Study for Trappsol Cyclo to Treat Alzheimer's Disease, Aiming to Reduce Amyloid Beta and Tau

Scientists are always looking for ways to develop better medications or other therapies that can help slow down the progression of the disease or improve symptoms. This might involve testing new drugs in the lab or in clinical trials with people who have Alzheimer's.

Alfa Cytology Launches Full-Scale Research Services for Pancreatic Cancer to Achieve Preclinical Safety Assessment

Alfa Cytology has announced its pancreatic cancer research services for anticancer therapy in early preclinical stages.